Tuberculosis Therapy
Multidrug-resistant tuberculosis treated successfully after liver transplant
Published in Medical Letter on the CDC and FDA, September 26th, 2004
"A 28-year-old female developed multidrug-resistant (MDR) tuberculosis lymphadenitis following a trip to India. She was initially treated with a four-drug regimen of first-line anti-tuberculosis medications, but when sensitivities indicated resistance to isoniazid and rifampin, her regimen was altered to ciprofloxacin (CFX), pyrazinamide (PZA), and ethambutol. She subsequently developed a rash, flu-like symptoms, and fever, which progressed to acute hepatic necrosis despite discontinuation of medication," researchers in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Alcohol Use
Drinking alcohol increases risk for fighting and injuries in adolescents - Coxiella
Biomarkers of whole Coxiella burnetii phase I identified - Cryptosporidiosis
Risk factors for cryptosporidiosis among immunocompetent persons reported - Fungal Infection
Zygoascus hellenicus fungemia found in stem cell transplant recipient - Tick-Borne Disease
PCR method to detect Anaplasma and Borrelia developed - AIDS/HIV Vaccine
HLA-A and -B expression high in subtype C HIV-infected Ethiopians - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
